✦ LIBER ✦

Temozolomide plus thalidomide promising in malignant melanoma

Book ID: 120859919
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200314010-00038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of combination thalidomide

Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

✍ Joseph I. Clark; James Moon; Laura F. Hutchins; Jeffrey A. Sosman; W. Martin Kas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Temozolomide plus thalidomide in patient

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A Phase II study

✍ Wen-Jen Hwu; Eric Lis; Jennifer H. Menell; Katherine S. Panageas; Lynne A. Lamb; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy‐naive patients with brain metastases. ## METHODS Patients with

`Maxamine' plus IL-2 shows promise in ma

`Maxamine' plus IL-2 shows promise in malignant melanoma

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Temozolomide plus docetaxel: potential i

Temozolomide plus docetaxel: potential in advanced melanoma

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Thalidomide used successfully in maligna

Thalidomide used successfully in malignant melanoma

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Temozolomide promising for malignant gli

Temozolomide promising for malignant gliomas in the elderly

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB